Traditional antidepressants such as SSRIs (e.g., sertraline, fluoxetine) and SNRIs (e.g., venlafaxine, duloxetine) remain the first-line treatment for depression. However, an estimated 30% of patients do not respond adequately to these medications. Ketamine therapy has emerged as an option for patients who have not found sufficient relief from conventional antidepressants. Here is how the two approaches compare.
| Factor | Ketamine | Antidepressants (SSRIs/SNRIs) |
|---|---|---|
| How it works | Blocks NMDA receptors, modulates glutamate, and may promote synaptogenesis | Increases availability of serotonin and/or norepinephrine in the brain |
| Speed of relief | Some patients report improvement within hours to days | Typically 4-8 weeks before full therapeutic effect |
| Administration | Intermittent sessions (oral, IV, or intranasal); not taken daily in most protocols | Daily oral pill; taken continuously, often for months or years |
| Cost | At-home oral: ~$350/appointment + $50-150/mo medication; generally not covered by insurance | Often $10-50/month with insurance; widely covered by most health plans |
| FDA status | Ketamine is FDA-approved as an anesthetic; used off-label for depression. Esketamine (Spravato) is FDA-approved for TRD. | Multiple SSRIs and SNRIs are FDA-approved for major depressive disorder |
| Side effects | Dissociation, nausea, dizziness (generally transient, resolving within hours) | Sexual dysfunction, weight gain, emotional blunting, insomnia, GI symptoms (may persist) |
| Evidence level | Growing clinical trial evidence, particularly for treatment-resistant depression | Extensive evidence over decades; established first-line treatment |
Different neurotransmitter targets: Traditional antidepressants primarily target the serotonin and norepinephrine systems, which is why they take weeks to build up therapeutic effects. Ketamine works on the glutamate system, the brain's most abundant excitatory neurotransmitter, and may promote rapid formation of new neural connections. This fundamentally different mechanism means that patients who have not responded to serotonin-based medications may still benefit from ketamine.
Speed of onset: One of the most researched aspects of ketamine is its potentially rapid antidepressant effect. While SSRIs may take 4-8 weeks to reach full effect, clinical studies have reported mood improvement with ketamine within hours to days. This may be particularly meaningful for patients experiencing severe symptoms or suicidal ideation.
Side effect profiles: Many patients discontinue antidepressants due to persistent side effects such as sexual dysfunction, weight gain, or emotional numbness. Ketamine's side effects, including dissociation and nausea, tend to be short-lived and occur primarily during and shortly after sessions. However, ketamine does carry a risk of misuse and is not appropriate for everyone.
Treatment model: Antidepressants require daily adherence, often over months or years, with gradual dose adjustments. Ketamine therapy is typically administered in discrete sessions with medical supervision, which some patients find more manageable and less burdensome than daily medication.
Ketamine is not typically used as a first-line replacement for antidepressants. It is most commonly considered when standard medications have not provided adequate relief. Some patients use ketamine alongside their existing medications. Any changes to your regimen should be discussed with your provider.
SSRIs gradually increase serotonin levels over weeks. Ketamine acts on the glutamate system and may promote rapid changes in neural connectivity, which is thought to explain the faster onset. The exact mechanisms are still being studied.
Both have side effect profiles that should be considered. SSRIs may cause persistent effects like sexual dysfunction and weight gain. Ketamine's side effects are generally transient but it carries risks of misuse. Neither is universally safer; the right choice depends on your health profile.
If two or more antidepressants have not worked, you may have treatment-resistant depression. Ketamine is one of several options for TRD. Learn more on our candidacy page or schedule a consultation to discuss your options.
Looking beyond traditional antidepressants?
Our physicians can help you evaluate whether ketamine therapy may be a good fit.
Check Appointment Availability